Kim, T. H., Kishimoto, M., Wei, J. C., Jeong, H., Nozaki, A., & Kobayashi, S. (2023). Brodalumab, an anti-interleukin-17 receptor A monoclonal antibody, in axial spondyloarthritis: 68-week results from a phase 3 study. Rheumatology (Oxford, England), 62(5), 1851–1859. https://doi.org/10.1093/rheumatology/keac522

Curtis, J. R., Yamaoka, K., Chen, Y. H., Bhatt, D. L., Gunay, L. M., Sugiyama, N., Connell, C. A., Wang, C., Wu, J., Menon, S., Vranic, I., & Gómez-Reino, J. J. (2023). Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial. Annals of the rheumatic diseases, 82(3), 331–343. https://doi.org/10.1136/ard-2022-222543

Connelly, K., Kandane-Rathnayake, R., Hoi, A., Louthrenoo, W., Hamijoyo, L., Luo, S. F., Wu, Y. J., Cho, J., Lateef, A., Lau, C. S., Chen, Y. H., Navarra, S., Zamora, L., Li, Z., An, Y., Sockalingam, S., Hao, Y., Zhang, Z., Chan, M., Katsumata, Y., … Morand, E. F. (2023). Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study. Arthritis & rheumatology (Hoboken, N.J.), 75(3), 401–410. https://doi.org/10.1002/art.42350

Chang, T. Y., Chao, T. F., Lin, C. Y., Lin, Y. J., Chang, S. L., Lo, L. W., Hu, Y. F., Chung, F. P., & Chen, S. A. (2023). Catheter ablation of atrial fibrillation in heart failure with impaired systolic function: An updated meta-analysis of randomized controlled trials. Journal of the Chinese Medical Association : JCMA, 86(1), 11–18. https://doi.org/10.1097/JCMA.0000000000000823

Lin, W. C., Tai, W. C., Chang, C. H., Tu, C. H., Feng, I. C., Shieh, M. J., Chung, C. S., Yen, H. H., Chou, J. W., Wong, J. M., Liu, Y. H., Huang, T. Y., Chuang, C. H., Tsai, T. J., Chiang, F. F., Lu, C. Y., Hsu, W. H., Yu, F. J., Chao, T. H., Wu, D. C., … Wei, S. C. (2023). Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study. Inflammatory bowel diseases, 29(11), 1730–1740. https://doi.org/10.1093/ibd/izac269

Sternberg, C. N., Petrylak, D. P., Bellmunt, J., Nishiyama, H., Necchi, A., Gurney, H., Lee, J. L., van der Heijden, M. S., Rosenbaum, E., Penel, N., Pang, S. T., Li, J. R., García Del Muro, X., Joly, F., Pápai, Z., Bao, W., Ellinghaus, P., Lu, C., Sierecki, M., Coppieters, S., … Quinn, D. I. (2023). FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(3), 629–639. https://doi.org/10.1200/JCO.21.02303

Chen, J. J., Wu, Y. C., Wang, J. S., & Lee, C. H. (2023). Liposomal bupivacaine administration is not superior to traditional periarticular injection for postoperative pain management following total knee arthroplasty: a meta-analysis of randomized controlled trials. Journal of orthopaedic surgery and research, 18(1), 206. https://doi.org/10.1186/s13018-023-03699-4

Jiang, R. S., Yan, K., Chiang, Y. F., & Chiang, P. J. (2023). The Effect of Chinese Herbal Medicine on Traumatic Anosmia: A Prospective, Randomized Clinical Trial. The Laryngoscope, 133(6), 1473–1479. https://doi.org/10.1002/lary.30676

Format:

Tsai, S. F., Yang, C. T., Liu, W. J., & Lee, C. L. (2023). Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study. EClinicalMedicine, 58, 101934. https://doi.org/10.1016/j.eclinm.2023.101934